StockData
IRadimed Corp logo

IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$83.45−1.39 (-1.64%)

Close on Nov 17, 2026Market cap $1.07BP/E 44.6Yield –

IRadimed operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

IRadimed's operating income for the twelve months ending Sep 30, 2026 was $28.86M, up 16.1% year over year. For fiscal 2025 it was $26.15M, up 19.0% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $26.15M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$26.15M+19.0%
FY2024Dec 31, 2024$21.97M+9.6%
FY2023Dec 31, 2023$20.04M+28.2%
FY2022Dec 31, 2022$15.63M+59.2%
FY2021Dec 31, 2021$9.82M–
FY2020Dec 31, 2020-$756.09K-108.7%
FY2019Dec 31, 2019$8.65M+44.0%
FY2018Dec 31, 2018$6.00M+367.2%
FY2017Dec 31, 2017$1.29M-88.2%
FY2016Dec 31, 2016$10.92M-5.2%
FY2015Dec 31, 2015$11.51M+275.5%
FY2014Dec 31, 2014$3.07M+10.0%
FY2013Dec 31, 2013$2.79M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$8.14M+19.1%
Q2 FY2026Jun 30, 2026$6.39M-5.8%
Q1 FY2026Mar 31, 2026$7.24M+33.2%
Q4 FY2025Dec 31, 2025$7.09M+22.3%
Q3 FY2025Sep 30, 2025$6.83M+18.0%
Q2 FY2025Jun 30, 2025$6.79M+20.6%
Q1 FY2025Mar 31, 2025$5.43M+14.4%
Q4 FY2024Dec 31, 2024$5.80M+12.4%
Q3 FY2024Sep 30, 2024$5.79M-2.0%
Q2 FY2024Jun 30, 2024$5.63M+13.4%
Q1 FY2024Mar 31, 2024$4.75M+18.5%
Q4 FY2023Dec 31, 2023$5.16M+21.3%
Q3 FY2023Sep 30, 2023$5.91M+42.9%
Q2 FY2023Jun 30, 2023$4.96M+19.1%
Q1 FY2023Mar 31, 2023$4.01M+30.3%
Q4 FY2022Dec 31, 2022$4.25M+36.8%
Q3 FY2022Sep 30, 2022$4.13M+33.9%
Q2 FY2022Jun 30, 2022$4.17M+125.9%
Q1 FY2022Mar 31, 2022$3.07M+73.0%
Q4 FY2021Dec 31, 2021$3.11M+377.6%
Q3 FY2021Sep 30, 2021$3.09M+293.4%
Q2 FY2021Jun 30, 2021$1.84M–
Q1 FY2021Mar 31, 2021$1.78M+141.0%
Q4 FY2020Dec 31, 2020$651.03K-70.9%
Q3 FY2020Sep 30, 2020$784.76K-68.8%
Q2 FY2020Jun 30, 2020-$2.93M-223.3%
Q1 FY2020Mar 31, 2020$737.24K-51.3%
Q4 FY2019Dec 31, 2019$2.24M+24.9%
Q3 FY2019Sep 30, 2019$2.52M+73.9%
Q2 FY2019Jun 30, 2019$2.38M+41.8%
Q1 FY2019Mar 31, 2019$1.51M+39.2%
Q4 FY2018Dec 31, 2018$1.79M+79.3%
Q3 FY2018Sep 30, 2018$1.45M+638.6%
Q2 FY2018Jun 30, 2018$1.68M+411.5%
Q1 FY2018Mar 31, 2018$1.09M–
Q4 FY2017Dec 31, 2017$999.75K-33.6%
Q3 FY2017Sep 30, 2017$196.06K–
Q2 FY2017Jun 30, 2017$327.58K–
Q1 FY2017Mar 31, 2017-$238.38K–
Q4 FY2016Dec 31, 2016$1.51M–

More IRadimed figures

See a number that looks wrong?